Holen Sie sich die Stockscreener-App
13.90
0.51%
0.07
Vorhandelsmarkt:
14.69
0.79
+5.68%
Schlusskurs vom Vortag:
$13.83
Offen:
$13.81
24-Stunden-Volumen:
1.08M
Relative Volume:
1.28
Marktkapitalisierung:
$1.18B
Einnahmen:
$17.49M
Nettoeinkommen (Verlust:
$-78.50M
KGV:
-11.58
EPS:
-1.2
Netto-Cashflow:
$-52.85M
1W Leistung:
-8.52%
1M Leistung:
-14.51%
6M Leistung:
+36.88%
1J Leistung:
+2.13%
1-Tages-Spanne:
$13.50
$14.17
1-Wochen-Bereich:
$13.50
$15.57
52-Wochen-Spanne:
$8.26
$16.99
Liquidia Corp Stock (LQDA) Company Profile
Firmenname
Liquidia Corp
Sektor
Branche
Telefon
919.328.4400
Adresse
419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC
Vergleichen Sie LQDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LQDA
Liquidia Corp
|
13.90 | 1.18B | 17.49M | -78.50M | -52.85M | -1.20 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.34 | 125.40B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
718.16 | 78.51B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
580.43 | 35.27B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
238.74 | 30.91B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beone Medicines Ltd Adr
|
245.71 | 26.37B | 3.32B | -860.46M | -1.04B | -8.32 |
Liquidia Corp Stock (LQDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-20 | Eingeleitet | Wells Fargo | Overweight |
| 2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-08-19 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-08-16 | Eingeleitet | Raymond James | Outperform |
| 2024-06-25 | Eingeleitet | Oppenheimer | Perform |
| 2024-01-05 | Bestätigt | Needham | Buy |
| 2022-09-19 | Fortgesetzt | Wedbush | Underperform |
| 2022-09-01 | Herabstufung | Wedbush | Neutral → Underperform |
| 2022-07-22 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2022-05-31 | Eingeleitet | BTIG Research | Buy |
| 2022-05-26 | Eingeleitet | BofA Securities | Buy |
| 2020-12-04 | Eingeleitet | H.C. Wainwright | Buy |
| 2020-11-20 | Herabstufung | Wedbush | Outperform → Neutral |
| 2018-11-08 | Fortgesetzt | Jefferies | Buy |
| 2018-09-05 | Eingeleitet | Wedbush | Outperform |
| 2018-08-20 | Eingeleitet | Jefferies | Buy |
| 2018-08-20 | Eingeleitet | Needham | Buy |
Alle ansehen
Liquidia Corp Aktie (LQDA) Neueste Nachrichten
Insider Sell: CFO and COO Michael Kaseta Sells 12,166 Shares of Liquidia Corp (LQDA) - GuruFocus.com
Liquidia’s chief commercial officer sells shares worth $9,146 By Investing.com - Investing.com Canada
Liquidia’s chief commercial officer sells shares worth $9,146 - Investing.com India
Liquidia Corp CFO Michael Kaseta sells shares worth $13,503 - Investing.com
Liquidia Corp Executives Sell Shares - TradingView
FDA Was Right to Delay Approving Liquidia's Yutrepia, Judge Says - Bloomberg Law
Liquidia Corp loses FDA lawsuit; Tyvaso DPI exclusivity stands - Investing.com
Liquidia Challenge To UTC's Tyvaso Exclusivity Fails - Law360
Atea Pharmaceuticals Appoints Arthur S. Kirsch to Board of Directors - GlobeNewswire Inc.
Bleakley Financial Group LLC Lowers Stock Position in Liquidia Co. (NASDAQ:LQDA) - Defense World
The Attractiveness of Investing In Liquidia Corp (LQDA) is Growing - Knox Daily
Liquidia Co. (NASDAQ:LQDA) Receives $25.38 Average Price Target from Brokerages - MarketBeat
Liquidia Corp's chief business officer sells $6,319 in stock - MSN
Life Sciences Group Of The Year: Cooley - Law360
Stock Performance Spotlight: Liquidia Corp (LQDA) Ends the Day at 15.74, Up by 3.89 - The Dwinnex
Liquidia Corp.: We Have Exposure To The Upside Now - Seeking Alpha
Liquidia Corp (LQDA) stock on the rise: An overview - US Post News
Arquitos Capital Management Q4 2024 Commentary - Seeking Alpha
This trade activity should not be overlooked: Liquidia Corp (LQDA) - SETE News
Liquidia Corp [LQDA] Investment Appeal on the Rise - Knox Daily
Liquidia Corporation's Long-Running Saga Is Coming To An End (NASDAQ:LQDA) - Seeking Alpha
Liquidia Corp's chief medical officer sells $31,785 in stock - MSN
Liquidia Co. (NASDAQ:LQDA) Insider Sells $31,785.00 in Stock - MarketBeat
Liquidia Corp's chief medical officer sells $31,785 in stock By Investing.com - Investing.com UK
Liquidia Technologies (LQDA) Moves 5.7% Higher: Will This Strength Last? - Yahoo Finance
Barclays PLC Purchases 72,591 Shares of Liquidia Co. (NASDAQ:LQDA) - Defense World
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 By Investing.com - Investing.com Australia
Rajeev Saggar Sells 6,249 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Roger Jeffs Sells 22,343 Shares of Liquidia Co. (NASDAQ:LQDA) Stock - MarketBeat
Liquidia Co. (NASDAQ:LQDA) General Counsel Russell Schundler Sells 16,393 Shares - MarketBeat
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock By Investing.com - Investing.com Australia
Liquidia's chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Australia
Liquidia’s chief commercial officer sells shares worth $98,504 By Investing.com - Investing.com Nigeria
Liquidia Corp chief business officer sells $56,650 in stock By Investing.com - Investing.com South Africa
Liquidia's chief commercial officer sells shares worth $98,504 - Investing.com India
Liquidia's chief medical officer Rajeev Saggar sells $73,613 in stock - Investing.com India
Liquidia Corp general counsel sells shares worth $193,109 - Investing.com India
Liquidia Corp chief business officer sells $56,650 in stock - Investing.com
Liquidia Corp CFO Michael Kaseta sells shares worth $275,298 - Investing.com
Liquidia Corp general counsel sells shares worth $193,109 By Investing.com - Investing.com UK
Liquidia’s (LQDA) Buy Rating Reiterated at Needham & Company LLC - Defense World
Analysts Set Liquidia Co. (NASDAQ:LQDA) Price Target at $25.38 - MarketBeat
Liquidia's (LQDA) "Buy" Rating Reaffirmed at Needham & Company LLC - MarketBeat
Breaking Down Liquidia: 4 Analysts Share Their Views - Benzinga
Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference - Yahoo Finance
Liquidia CEO to Present at J.P. Morgan Healthcare Conference 2025 in San Francisco - StockTitan
Yutrepia's Launch: A Catalyst for Liquidia (LQDA) - substack.com
Liquidia Co. (NASDAQ:LQDA) Shares Sold by Geode Capital Management LLC - MarketBeat
Finanzdaten der Liquidia Corp-Aktie (LQDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.14%
2.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):